Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
Crossref DOI link: https://doi.org/10.1186/s12872-015-0100-7
Published Online: 2015-09-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiffman, Dov
Perez, Marco V.
Bare, Lance A.
Louie, Judy Z.
Arellano, Andre R.
Devlin, James J.
License valid from 2015-09-29